Yosuke Matsumoto

ORCID: 0000-0001-7416-3222 · 2 papers in corpus

case-report 2020

A case of non-small cell lung cancer with danazol-dependent aplastic anemia induced by pembrolizumab

Current problems in cancer ·doi:10.1016/j.currproblcancer.2020.100686

Programmed cell death protein 1 immune checkpoint inhibitor is an effective treatment for non-small cell lung cancer. Although hematological immune-related adverse events induced by antiprogrammed-cell-death-protein-1 immunotherapy have bee…

observational 2019

Endometriosis and Recurrent Pregnancy Loss as New Risk Factors for Venous Thromboembolism during Pregnancy and Post-Partum: The JECS Birth Cohort

Thrombosis and haemostasis ·doi:10.1055/s-0039-1677733

BACKGROUND: Since venous thromboembolism (VTE) is one of the causes of maternal mortality, several guidelines recommend prophylaxis using low molecular weight heparin for women in high-risk groups. The number of large population-based studi…